Study Evaluating the Safety and Tolerability of Single Ascending Dose (SAD) SLV-351 in Healthy Subjects

NCT00581191 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SLV-351

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

[object Object]